Skip to content

Drug interactions

Dacomitinib + Fluoxetine

Severity: Minor

Dacomitinib and Fluoxetine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dacomitinib is a strong CYP2D6 inhibitor. Fluoxetine is a CYP2D6 substrate but is also a strong CYP2D6 inhibitor itself, so the rise in fluoxetine exposure is likely small, and fluoxetine has a wide therapeutic margin. The clinical effect is generally limited to modestly increased fluoxetine adverse effects.

What this interaction means in plain words

Dacomitinib and Fluoxetine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dacomitinib belongs to Oncology; Fluoxetine belongs to Central Nervous System.

Evidence level: Low

Why it happens

CYP2D6 inhibition by dacomitinib reduces fluoxetine metabolism.

What to do

No routine dose change is needed. Monitor for increased fluoxetine adverse effects such as nausea, agitation or insomnia.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dacomitinib and Fluoxetine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dacomitinib with Fluoxetine?

MediHelp rates the interaction as minor. Dacomitinib and Fluoxetine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dacomitinib is a strong CYP2D6 inhibitor. Fluoxetine is a CYP2D6 substrate but is also a strong CYP2D6 inhibitor itself, so the rise in fluoxetine exposure is likely small, and fluoxetine has a wide therapeutic margin. The clinical effect is generally limited to modestly increased fluoxetine adverse effects.

How serious is the interaction between Dacomitinib and Fluoxetine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor for increased fluoxetine adverse effects such as nausea, agitation or insomnia.

What other medicines interact with Fluoxetine?

MediHelp also lists interactions of Fluoxetine with, for example, Isocarboxazid, Mavacamten, Methylene blue. The full list is on the Fluoxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in